Oxford University Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials
• Forums

GPPAD-POInT (Global Platform of Autoimmune Diabetes - Primary Oral Insulin Trial)
Condition:   Diabetes Mellitus, Type 1 Interventions:   Drug: Oral Insulin;   Other: Placebo Sponsors:   Technische Universität München;   The Leona M. and Harry B. Helmsley Charitable Trust;   Helmholtz Zentrum München;   University Hospital Carl Gustav Carus;   Kinderkrankenhaus auf der Bult;   Skane University Hospital;   Universitaire Ziekenhuizen Leuven;   Medical Uni versity of Warsaw;   University of Oxford, Clinical Vaccine Research and Immunisation Education Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 7, 2017 Category: Research Source Type: clinical trials